Stemcells (STEM) Posts Q1 Loss of 17c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500, Nasdaq pare declines as AI rout teeters; healthcare, staples gain
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts STEM Hot Sheet
Price: $3.61 +0.56%
Revenue Growth %: +5.6%
Financial Fact:
Loss from operations: -8.88M
Today's EPS Names:
NTRP, FMCB, LOOP, More
Revenue Growth %: +5.6%
Financial Fact:
Loss from operations: -8.88M
Today's EPS Names:
NTRP, FMCB, LOOP, More
Join SI Premium – FREE
Stemcells (NASDAQ: STEM) reported Q1 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $284 thousand versus the consensus estimate of $290 thousand.
For earnings history and earnings-related data on Stemcells (STEM) click here.
For earnings history and earnings-related data on Stemcells (STEM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
- U.S. Bancorp beats earnings despite revenue miss
- TD Cowen on Establishment Labs Inc. (ESTA): 'The Selloff Looks Overdone as a Major FDA Catalyst Approaches'
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
